KC law firms help secure $73.5M EpiPen settlement for wholesaler buyers
Mylan's settlement with drug wholesalers comes on the heels of the company reaching a $264 million settlement for consumers ...
Pfizer shares zoom nearly 9% after marketing and supply agreement with Mylan Pharmaceuticals
Pfizer shares surged 8.6% to Rs 4,448.35 after announcing a marketing and supply agreement with Mylan Pharmaceuticals for Ativan and Pacitane. The five-year deal aims to enhance distribution and ...
Harvard Business School7y
Mylan Lab's Proposed Merger with King Pharmaceuticals—courseware
White, Lucy. "Mylan Lab's Proposed Merger with King Pharmaceuticals—courseware." Harvard Business School Spreadsheet Supplement 214-709, May 2014. (Revised June 2016.) ...
moneycontrol.com7y
Mylan Laboratories
As many as 277,267 bottles of Candesartan Cilexetil tablets manufactured by Mylan Laboratories are being recalled by Sandoz Inc, for whom they were made, in an ongoing recall due to "failed ...
JD Supra9d
The Precedent: Federal Circuit Adds Clarity to Personal Jurisdiction and Obviousness-Type Double Patenting Analyses in Regeneron Pharms
In this edition of The Precedent, we outline the decision in Regeneron Pharms., Inc. v. Mylan Pharms. Inc. In Regeneron Pharms., Inc. v. Mylan ...
pharmaphorum8d
Amgen faces first Neulasta biosimilar rival as FDA approves Mylan drug
Amgen’s Neulasta is set to face its first competition in the US after the FDA approved Mylan’s biosimilar version of the blockbuster cancer infection biologic. Neulasta brought in $4.5 billion ...
Life Sciences IP Review3d
Novo Nordisk strikes again over Wegovy generic
The multinational claims Mylan Pharmaceuticals’ generic of its blockbuster weight loss drug infringes another new patent | Complaint similar but separate to previous lawsuit against Mylan and Sun ...